Please use this identifier to cite or link to this item:
http://localhost:8080/xmlui/handle/123456789/9443
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Pan, Sheng-Wei | - |
dc.contributor.author | Catanzaro, Donald G. | - |
dc.contributor.author | Syed, Rehan R. | - |
dc.contributor.author | Hillery, Naomi | - |
dc.contributor.author | Ho, Mei-Lin | - |
dc.date.accessioned | 2024-12-20T04:16:05Z | - |
dc.date.available | 2024-12-20T04:16:05Z | - |
dc.date.issued | 2023-10 | - |
dc.identifier.citation | Original Article | en_US |
dc.identifier.uri | http://localhost:8080/xmlui/handle/123456789/9443 | - |
dc.description.abstract | Abstract Objectives: To assess associations between disease severity in index TB patients and QuantiFERON-TB Gold Plus (QFT-Plus) results in contacts, and predictors for QFT-Plus conversion in contacts over 6e12 months. Methods: TB patients (n Z 295) and the contacts (n Z 1051) were enrolled during 2018e2021 with QFT-Plus performed at baseline and months 6 and 12. A strong CD8 response was defined as TB2 interferon gamma (IFN-g) response minus TB1 >0.6 IU/ml and stringent conversion as change from QFT-plus negative to high-positive QFT-Plus (TB1 or TB2 IFN-g responses >0.7 IU/ml). Results: Contacts with index TB patients with sputum smear >1þ was associated with positive QFT-Plus compared to those without (p < 0.001). Contacts with index TB patients with bilateral lung disease were more likely to have strong CD8 responses than those without (p Z 0.038). QFT-Plus stringent conversion occurred in 9.7% of contacts over 6e12 months. A TB1 IFN-g response 0.03 IU/ml combined with a TB2 0.06 IU/ml was predictive of a 19-fold increased risk for QFT-Plus stringent conversion in contacts (odd ratio 19.565 [8.484e45.116], p < 0.001). Conclusion: Bacterial burden and bilateral lung disease of index TB patients were associated with positive QFT-Plus and strong CD8 responses in contacts. TB1 and TB2 IFN-g responses were synergistically predictive of stringent conversion in contacts. | en_US |
dc.language.iso | en_US | en_US |
dc.publisher | Elsevier Taiwan LLC | en_US |
dc.subject | Interferon-gamma release assay | en_US |
dc.subject | QuantiFERON-TB Gold plus | en_US |
dc.subject | Stringent conversion | en_US |
dc.subject | Tuberculosis contacts | en_US |
dc.title | Predicting stringent QuantiFERON-TB Gold Plus conversions in contacts of tuberculosis patients | en_US |
dc.type | Article | en_US |
Appears in Collections: | VOL 56 NO 5 2023 |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
1073-1083.pdf | 2.07 MB | Adobe PDF | View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.